©1995 by The American Society for Biochemistry and Molecular Biology, Inc.
Interleukin-11 Induces Complex Formation of Grb2, Fyn, and JAK2 in 3T3L1 Cells (*)

(Received for publication, September 13, 1995)

Xin-Yuan Wang (1) (2) Douglas K. Fuhrer (1) (2) Mark S. Marshall (1) (2) (3) Yu-Chung Yang (1) (2) (3)(§)

From the  (1)Department of Medicine (Hematology/Oncology), (2)Walther Oncology Center, and (3)Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, Indiana 46202

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES

ABSTRACT

Previous studies suggested that interleukin-11 (IL-11) induces the activation of mitogen-activated protein kinase (MAPK) in mouse 3T3L1 cells. However, the mechanisms by which IL-11 activates MAPK remain elusive. Our present results show that IL-11 promotes the formation of the active GTP-bound form of Ras, suggesting that IL-11 actions may be transduced in part through the Ras/MAPK signaling pathway. By immunoblotting and immunoprecipitation, we further demonstrate the association of tyrosine phosphoproteins with Grb2, an adaptor protein serving as a key intermediate for Ras activation. These phosphotyrosine-containing proteins have been subsequently identified to be JAK2, Fyn, and Syp. JAK2 and Fyn are transiently associated with Grb2 upon stimulation with IL-11, suggesting that JAK2 and Fyn may be involved in transducing signals from the IL-11 receptorbulletglycoprotein 130 to the Ras system through Grb2. Taken together, these results suggest that IL-11-induced interactions of JAK2, Fyn, and Grb2 may not only provide a novel mechanism for the activation of the Ras/MAPK system but also indicate cross-talk among diverse signaling pathways.


INTRODUCTION

IL-11 (^1)is a stromal fibroblast-derived cytokine (1, 2) that plays essential roles in a variety of biological systems. Previous studies have suggested that IL-11 depends on gp130 to transduce its signals into cells(3) . gp130 is an IL-6 receptor-associated signal transducer and is shared by receptor complexes for leukemia inhibitor factor, oncostatin M, ciliary neurotrophic factor, and IL-11(3) . It has been reported that gp130 associates with Janus kinase 2 (JAK2) tyrosine kinase, which is tyrosine-phosphorylated and activated upon IL-11, IL-6, ciliary neurotrophic factor, oncostatin M, or leukemia inhibitor factor stimulation of cells(4, 5) . The response of JAK2 to IL-6 is blocked by point mutations or deletions of the membrane proximal portion of gp130 (6) . It was further demonstrated that mitogen-activated protein kinase (MAPK) is tyrosine-phosphorylated and activated following IL-11 stimulation(7) . MAPK has been shown to be a key target of Ras(8) , a crucial downstream signaling partner for growth factor receptor tyrosine kinases(9, 10) . Thus, it is possible that Ras may also be involved in IL-11 signal transduction.

Growth factor receptor binding protein 2 (Grb2) is an adaptor protein containing a Src homology type 2 (SH2) domain flanked by two Src homology type 3 (SH3) domains(9, 10, 11) . Through its SH3 domains, Grb2 constitutively binds a Ras guanine nucleotide-releasing factor (GNRF) like Sos or Cdc25, which activates Ras by replacing Ras-bound GDP with GTP. In the absence of cellular activation, the Grb2bulletGNRF complex is located in the cytoplasm. Upon activation by growth factors, the SH2 domain of Grb2 binds activated tyrosine-phosphorylated receptors or receptor-associated tyrosine phosphoproteins, thus bringing GNRF to the plasma membrane where Ras is located(9, 10, 11) . Through its adaptor-like function, Grb2 plays a key role in linking cell receptor tyrosine kinases and associated tyrosine phosphoproteins with the Ras pathway.

The interactions of Grb2 with receptor tyrosine kinases have been studied in the epidermal growth factor receptor (EGFR) and the insulin receptor (IR) systems(12, 13) . Ligand binding leads to EGFR autophosphorylation on multiple tyrosine residues. Subsequently, the SH2 domain of Grb2 becomes attached to tyrosine residues of the EGFR, thus relocating Sos to the plasma membrane. In contrast to the EGFR, stimulation of the IR involves two additional proteins, Shc and insulin receptor substrate-1. Upon stimulation with insulin, Shc and insulin receptor substrate-1 become tyrosine-phosphorylated and bind to Grb2 in order to recruit the Grb2bulletSos complex to the cell membrane.

In marked contrast to receptor tyrosine kinases like EGFR and IR, the IL-11 signal transducer gp130 has no kinase domains (3) and needs to activate membrane-associated non-receptor tyrosine kinases for mediating its effects. It is therefore interesting to elucidate which non-receptor tyrosine kinases are recruited by IL-11 to interact with Grb2, hence transducing signals from the activated IL-11 receptorbulletgp130 complex to the Ras/MAPK pathway.


EXPERIMENTAL PROCEDURES

Materials

Recombinant human IL-11 (specific activity, 2.5 times 10^6 units/mg) was generously provided by Genetics Institute (Cambridge, MA). Anti-phosphotyrosine monoclonal antibody (4G10), and affinity-purified anti-gp130 and anti-JAK2 antibodies were from Upstate Biotechnology, Inc. (Lake Placid, NY). Affinity-purified anti-Grb2 and anti-Fyn antibodies, together with anti-Fyn monoclonal antibody were from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). Anti-Ras monoclonal antibody (Y13-259) was from Oncogene Science, Inc. (Cambridge, MA). Anti-Syp was a gift from Dr. Gen-Sheng Feng (Indiana University School of Medicine). Horseradish peroxidase-conjugated anti-mouse and anti-rabbit IgG were from Amersham Corp., and horseradish peroxidase-conjugated anti-rat IgG was from Zymed Laboratories, Inc. (San Francisco, CA).

Treatment of 3T3-L1 Cells with IL-11, Immunoprecipitation, and Immunoblotting

3T3L1 mouse preadipocytes were maintained in Dulbecco's modified Eagle's medium containing 10% fetal bovine serum, 100 units/ml penicillin, 100 µg/ml streptomycin, and 2 mML-glutamine. Confluent cells were stimulated without or with 500 ng/ml IL-11 at 37 °C as indicated under ``Results and Discussion.'' 500 ng/ml has been determined to be the optimum concentration of IL-11 on 3T3L1 cells from our previous studies(7) . Reactions were stopped by placing dishes of attached cells on ice and adding ice-cold phosphate-buffered saline containing 2 mM sodium orthovanadate to the cells. Cells were scraped off the plate, washed in ice-cold phosphate-buffered saline, and then centrifuged at 500 times g for 5 min at 4 °C. The cells were then lysed in modified RIPA buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1 mM EGTA, 1% Nonidet P-40, 0.25% sodium deoxycholate, 1 mM phenylmethylsulfonyl fluoride, 1 mM NaF, 1 mM sodium orthovanadate, 1 µg/ml aprotinin, and 1 µg/ml leupeptin). Solubilized proteins were collected after centrifugation (13,000 times g for 10 min at 4 °C) and used for immunoprecipitations with the appropriate antibodies for 4-h incubation at 4 °C with rotation. The immune complexes were further incubated with protein A-agarose beads (Upstate Biotechnology, Inc., Lake Placid, NY) for 1 h at 4 °C with rotation and then washed five times with modified RIPA buffer. The immunoprecipitates were separated by 12 or 7.5% SDS-polyacrylamide gel electrophoresis (PAGE) and transferred to polyvinylidine difluoride membranes. The membranes were then immunoblotted with the appropriate antibodies, and antibody-bound proteins were visualized using horseradish peroxidase-conjugated anti-mouse, anti-rabbit, or anti-rat IgG and ECL (Amersham Corp.) according to the manufacturer's specifications.

In Vitro Binding Assay

GST-Raf (amino acids 51-149) fusion protein and GST alone as a control were freshly prepared for in vitro binding experiments as described(14) . 3T3L1 cells were treated in the absence or presence of 500 ng/ml IL-11 at 37 °C as indicated under ``Results and Discussion.'' For in vitro binding studies, glutathione-Sepharose beads (Pharmacia Biotech Inc.) with bound fusion proteins (approximately 5 µg of fusion protein/binding reaction) were incubated with cell lysates in digitonin lysis buffer (1% digitonin, 150 mM NaCl, 2 mM EDTA, 50 mM Tris, pH 8.0, 2 mM sodium orthovanadate, 10 µg/ml aprotinin, and 10 µg/ml leupeptin) at 4 °C for 12-14 h. The beads were washed three times with digitonin lysis buffer before the bound proteins were separated by SDS-PAGE and immunoblotted with anti-Ras.


RESULTS AND DISCUSSION

IL-11 Induces the GTP-Ras Formation in 3T3L1 Cells

In order to test whether Ras was activated by IL-11, the GST-Raf in vitro binding assay was performed using lysates from unstimulated and IL-11-treated 3T3L1 cells. It has recently been shown that Ras protein interacts directly with GST-Raf in vitro, and the binding of Ras and GST-Raf is dependent on the activation of Ras loaded with GTP rather than GDP(14) . Therefore, the in vitro binding assay of Ras and GST-Raf is suggested to be a useful approach to verify the activation of Ras(14) . In this study, we demonstrated that IL-11 induces complex formation between Ras and GST-Raf (amino acids 51-149) in vitro (Fig. 1). 3T3L1 cells were treated without or with 500 ng/ml IL-11 for 3 min and lysed with digitonin-containing lysis buffer. Cell lysates were immunoprecipitated with anti-Ras (Y13-259) or incubated with GST-Raf fusion protein or GST alone (as a negative control) immobilized to glutathione-Sepharose. The samples were washed, and bound proteins were separated by SDS-PAGE and immunoblotted with anti-Ras Ab (Y13-259). As shown in Fig. 1, stimulation of 3T3L1 cells with IL-11 had no effect on the protein level of Ras as was determined by immunoprecipitation with anti-Ras. Ras complexed with GST-Raf fusion proteins in the lysates from IL-11-stimulated 3T3L1 cells, whereas no GST-Raf-associated Ras was detected from unstimulated 3T3L1 cells. These results in conjunction with our previous studies (7) indicate that IL-11 signaling is at least in part mediated through the Ras/MAPK pathway.


Figure 1: IL-11 induces the association of Ras with GST-Raf in vitro. 3T3L1 cells were untreated or stimulated with IL-11 (500 ng/ml) for 3 min. Cell lysates were incubated with anti-Ras mAbs (Y13-238), GST-Raf fusion protein, or GST protein. The bound proteins were separated by 12% SDS-PAGE and immunoblotted with anti-Ras mAbs (Y13-259).



Phosphotyrosine-containing Proteins Associate with Grb2 in 3T3L1 Cells

The adaptor protein Grb2 is a key intermediate to facilitate protein-protein interactions and to transduce signals from ligand-activated membrane receptors to the Ras/MAPK pathway. To analyze the pattern of phosphotyrosine-containing proteins associated with Grb2 following IL-11 stimulation, lysates in modified RIPA buffer from IL-11-treated or untreated 3T3L1 cells were immunoprecipitated with anti-Grb2 antibody, and the precipitated proteins were analyzed by immunoblotting with anti-phosphotyrosine mAbs (4G10). As shown in Fig. 2, Grb2 constitutively associated with a tyrosine phosphoprotein with a molecular mass around 75 kDa, and IL-11 stimulation did not seem to affect their association. However, IL-11 induced two more phosphotyrosine-containing proteins of 130 and 60 kDa to complex with Grb2. After IL-11 treatment, the association of these two phosphotyrosine-containing proteins with Grb2 occurred at 1 min, could still be observed at 3 min, and completely disappeared at 7 min. 1 and 7 min are selected to be the two time points of IL-11 treatment for subsequent experiments. The same immunoprecipitates were reblotted with anti-Grb2 to verify the same amount of Grb2 in each immunoprecipitate. The 75-kDa tyrosine phosphoprotein was further identified as Syp (data not shown). Syp is a newly discovered protein-tyrosine phosphatase(15) , and the function of its association with Grb2 in IL-11-triggered signal transduction requires further investigation.


Figure 2: Grb2 associates with phosphotyrosine-containing proteins. 3T3L1 cells were untreated or stimulated by IL-11 (500 ng/ml) for the indicated times. Cell lysates were immunoprecipitated with anti-Grb2. The immunoprecipitates (IP) were resolved by SDS-PAGE and immunoblotted by anti-phosphotyrosine mAb (4G10) and anti-Grb2.



Grb2 Associates with Tyrosine-phosphorylated Fyn in Response to IL-11

To identify the 60-kDa Grb2-associated tyrosine-phosphorylated protein, anti-Grb2 immunoprecipitates were immunoblotted with anti-Shc. Shc has been shown to complex with Grb2 and activate the Ras signaling pathway upon stimulation with several cytokines(16, 17) . However, in our experiments Shc was not detected in anti-Grb2 immunoprecipitates from both unstimulated and IL-11-treated 3T3-L1 cells (data not shown). We therefore examined whether Src family tyrosine kinases, including Fyn, Yes, and Src, are possible candidates for this 60-kDa tyrosine-phosphorylated protein. Fyn, Yes, and Src have been determined from our previous studies to be the three Src family kinases expressed in 3T3L1 cells (data not shown). As shown in Fig. 3A, Fyn was not present in anti-Grb2 immunoprecipitates from unstimulated cells. It appeared in anti-Grb2 immunoprecipitates after cells were stimulated with IL-11 for 1 min and disappeared after cells were exposed to IL-11 for 7 min. Src and Yes could not be detected in anti-Grb2 immunoprecipitates from either unstimulated or IL-11-treated 3T3L1 cells (data not shown). The reciprocal immunoprecipitation and immunoblotting confirmed the presence of Grb2 in the anti-Fyn immunoprecipitates after cells were stimulated by IL-11 for 1 min, as shown in Fig. 3B. Fyn has a basal level of tyrosine phosphorylation in the unstimulated 3T3-L1 cells. However, tyrosine phosphorylation of Fyn was enhanced transiently following IL-11 stimulation (Fig. 3B). Fyn and other Src family kinases have been reported to be associated with signaling molecules, including phospholipase C-2 and PI3-kinase, which phosphorylates the Asp-3 position of phosphatidylinositol in various cytokine signal transduction mechanisms(18, 19, 20) . It has also been reported that Src family kinases are involved in the regulation of Ras activity. The Ras GTP-activating protein, an important regulator of the Ras function, was found in complexes with v-Src and c-Src and was phosphorylated by activated Src kinase in v-Src- and c-Src-transformed cells(21) . In NIH3T3 fibroblasts expressing oncogenic and transformation-defective variants of the Src family kinase p56, tyrosine phosphorylation and activation of Ras GTP-activating protein required the enzymatic activation and myristoylation of p56(22) . Recently, the p120 protooncogene product has been shown to form a complex with Fyn, Grb2, and PI3-kinase(23) . The association of p120 with Fyn and PI3-kinase was markedly increased by T cell activation. In contrast, the association of p120 with Grb2 did not change upon T cell activation. Our present results further suggest that Fyn can be recruited to interact with Grb2 following IL-11 stimulation, thus taking a part in transducing signals from the IL-11 receptorbulletgp130 complex to the Ras pathway.


Figure 3: Tyrosine-phosphorylated Fyn associates with Grb2 in response to IL-11. 3T3L1 cells were treated without or with IL-11 (500 ng/ml) for the indicated times. Cell lysates were immunoprecipitated with either anti-Grb2 (A) or anti-Fyn (B). The immunoprecipitates (IP) were resolved by SDS-PAGE and sequentially immunoblotted with anti-Fyn and anti-Grb2 (A) or anti-Grb2, anti-phosphotyrosine mAb (4G10), and anti-Fyn (B).



IL-11 Induces Tyrosine-phosphorylated JAK2 to Complex with Grb2 and Fyn as well as gp130

The 130-kDa Grb2-bound tyrosine-phosphorylated protein has a similar molecular weight as the JAK family tyrosine kinases. To test whether Grb2 binds JAK family tyrosine kinases, cell lysates were immunoprecipitated with either anti-Grb2 or anti-JAK2 antibodies, and these immune complexes were then analyzed by immunoblotting with anti-JAK2 and anti-Grb2. JAK2 can be detected in anti-Grb2 immunoprecipitates only after cells were stimulated by IL-11 for 1 min but not from control cells or cells that were exposed to IL-11 for 7 min (Fig. 4A). Related to this experiment, Grb2 was present in anti-JAK2 immunoprecipitates only after cells were treated by IL-11 for 1 min (Fig. 4B). JAK1 was not detected in anti-Grb2 immunoprecipitates from both unstimulated and IL-11-treated 3T3-L1 cells (data not shown). Fig. 4B also shows that tyrosine phosphorylation of JAK2 is transiently induced after IL-11 treatment. Fyn can also be found in anti-JAK2 immunoprecipitates after 3T3L1 cells were stimulated by IL-11 (Fig. 4B). The results demonstrate that IL-11 induces Grb2 and Fyn to complex with tyrosine-phosphorylated JAK2. JAK kinase activation may result in tyrosine phosphorylation and activation of the Stat family transcription factors, which were originally described in the interferon system(24) . Previous studies have shown that JAK2 associates with growth hormone receptor and erythropoietin receptors and is activated by the ligand receptor binding(25, 26) . It has been reported (4) and is confirmed in this paper that JAK2 associates with IL-11 signal transducer gp130 (Fig. 4C). By association with gp130 and Grb2, JAK2 appears to play a critical role in transducing signals from the activated IL-11 receptorbulletgp130 complex to the Ras/MAPK pathway via Grb2. Our experiments further showed that JAK2 associates with Fyn after IL-11 treatment (Fig. 4B). It has been theorized that protein-protein interactions may cause a conformational change in the Src family kinases, thus leading to the activation of the Src family kinases(27) . JAK2 has also been found to form a complex containing Src and PI3-kinase in response to IL-3 in NIH3T3 cells(28) . It is therefore possible that JAK2 may associate with and hence activate Fyn after IL-11 stimulation.


Figure 4: IL-11 induces tyrosine-phosphorylated JAK2 to complex with Grb2 and Fyn as well as gp130. 3T3L1 cells were treated without or with IL-11 (500 ng/ml) for the indicated times. Cell lysates were immunoprecipitated with anti-Grb2 (A), anti-JAK2 (B), or anti-gp130 (C). The immunoprecipitates (IP) were resolved by SDS-PAGE and sequentially immunoblotted with anti-JAK2 and anti-Grb2 (A), anti-Grb2, anti-Fyn (mAb), anti-phosphotyrosine mAb (4G10), and anti-JAK2 (B), or anti-JAK2 and anti-gp130 (C).



In summary, our data demonstrate that IL-11 stimulation induces a novel complex formation among JAK2, Fyn, and Grb2. The complex may serve to propagate signals originating from the IL-11 receptorbulletgp130 or alter the subcellular location of key signaling molecules such as Grb2-bound Ras GNRF. Grb2-complexed GNRFs identified so far are Sos1(29) , Sos2 (29) , Cdc25(30) , and C3G(31) . Our preliminary experiments failed to demonstrate the association between mSos1 and JAK2 or Fyn (data not shown). Further investigations will be required to identify the Grb2-bound GNRF, which is involved in IL-11-induced Ras activation. In addition to providing a novel mechanism that activates the Ras/MAPK signaling pathway, IL-11-induced complex formation of Grb2, JAK2, and Fyn may also represent the interactions among JAK/Stat, Ras/MAPK, and other Src family kinase-related signaling pathways. These interactions may result in diverse signaling pathways functioning in concert to dictate different cellular responses.


FOOTNOTES

*
This work was supported by United States Public Health Service Grants R01DK43105 and R01HL48819 (to Y.-C. Y). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore by hereby marked ``advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§
Scholar of the Leukemia Society of America. To whom correspondence should be addressed: Walther Oncology Center, Indiana University School of Medicine, 975 W. Walnut St., IB 540, Indianapolis, IN 46202. Tel.: 317-274-7512; Fax: 317-274-7592.

(^1)
The abbreviations used are: IL, interleukin; gp, glycoprotein; JAK, Janus kinase; MAPK, mitogen-activated protein kinase; Grb2, growth factor receptor binding protein 2; SH, Src homology type; GNRF, guanine nucleotide-releasing factor; EGFR, epidermal growth factor receptor; IR, insulin receptor; PAGE, polyacrylamide gel electrophoresis; mAb, monoclonal antibody; PI3-kinase, phosphatidylinositol 3-kinase; GST, glutathione S-transferase.


ACKNOWLEDGEMENTS

We thank Dr. Gen-Sheng Feng for providing anti-Syp antibody and reading the manuscript, and Dr. Tetsuzo Tauchi for helpful discussion.


REFERENCES

  1. Paul, S. R., Bennett, F., Calvetti, J. A., Kelleher, K., Wood, C. R., O'Hara, R. M., Jr., Leary, A. C., Sibley, B., Clark, S. C., Williams, D. A., and Yang, Y.-C. (1990) Proc. Natl. Acad. Sci. U. S. A. 87, 7512-7516 [Abstract]
  2. Yang, Y.-C. (1993) Stem Cells 11, 474-486 [Abstract]
  3. Yin, T., Taga, T., Tsang, M., Yasukawa, K., Kishimoto, T., and Yang, Y.-C. (1993) J. Immunol. 151, 2555-2561 [Abstract/Free Full Text]
  4. Yin, T., Yasukawa, K., Taga, T., Kishimoto, T., and Yang, Y.-C. (1994) Exp. Hematol. 22, 467-472 [Medline] [Order article via Infotrieve]
  5. Boulton, T. G., Stahl, N., and Yancopoulos, G. D. (1994) J. Biol. Chem. 269, 11648-11655 [Abstract/Free Full Text]
  6. Narazaki, M., Witthuhn, B. A., Yoshida, K., Silvennoinen, O., Yasukawa, K., Ilhe, J. N., Kishimoto, T., and Taga, T. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 2285-2289 [Abstract]
  7. Yin, T., and Yang, Y.-C. (1994) J. Biol. Chem. 269, 3731-3738 [Abstract/Free Full Text]
  8. Cobb, M. H., and Goldsmith, E. J. (1995) J. Biol. Chem. 270, 14843-14846 [Free Full Text]
  9. Marshall, M. S. (1993) Trends Biochem. Sci. 18, 250-254 [Medline] [Order article via Infotrieve]
  10. Margolis, B., and Skolnik, E. Y. (1994) J. Am. Soc. Nephrol. 5, 1288-1299 [Abstract]
  11. Lowenstein, E. J., Daly, R. J., Batzer, A. G., Li, W., Margolis, B., Lammers, R., Ullrich, A., Skolnik, E. Y., Bar-Sagi, D., and Schlessinger, J. (1992) Cell 70, 431-442 [Medline] [Order article via Infotrieve]
  12. Schlessinger, J. (1993) Trends Biochem. Sci. 18, 273-275 [Medline] [Order article via Infotrieve]
  13. Skolnik, E. Y., Batzer, A., Li, N., Lee, C. H., Lowenstein, E., Mohammadi, M., Margolis, B., and Schlessinger, J. (1993) Science 260, 1953-1955 [Medline] [Order article via Infotrieve]
  14. Tauchi, T., Feng, G.-S., Marshall, M. S., Shen, R., Mantel, C., Pawson, T., and Broxmeyer, H. E. (1994) J. Biol. Chem. 269, 25206-25211 [Abstract/Free Full Text]
  15. Feng, G.-S., Hui, C.-C., and Pawson, T. (1993) Science 259, 1607-1611 [Medline] [Order article via Infotrieve]
  16. Matsuguchi, T., Salgia, R., Hallek, M., Eder, M., Druker, B., Ernst, T., and Griffin, J. D. (1994) J. Biol. Chem. 269, 5016-5021 [Abstract/Free Full Text]
  17. Welham, M. J., Duronio, V., Leslie, K., Bowtell, D., and Schrader, J. W. (1994) J. Biol. Chem. 269, 21165-21176 [Abstract/Free Full Text]
  18. Pleiman, C., Clark, M., Timson, G., Winitz, S., Coggeshall, K., Johnson, G., Shaw, A., and Cambier, J. (1993) Mol. Cell. Biol. 13, 5877-5887 [Abstract]
  19. Prasad, K., Janssen, O., Kapeller, R., Raab, M., Cantley, L., and Rudd, C. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 7366-7370 [Abstract]
  20. Koyama, S., Yu, H., Dalgarno, D., Shin, T., Zydowsky, D., and Schreiber, S. (1993) Cell 72, 945-952 [Medline] [Order article via Infotrieve]
  21. Brott, B. K., Decker, S., Shafer, J., Gibbs, J. B., and Jove, R. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 755-759 [Abstract]
  22. Ellis, C., Liu, X., Anderson, D., Abraham, N., Veillette, A., and Pawson, T. (1991) Oncogene 6, 895-901 [Medline] [Order article via Infotrieve]
  23. Fukazawa, T., Reedquist, K. A., Trub, T., Soltoff, S., Panchamoorthy, G., Druker, B., Cantley, L., Shoelson, S. E., and Band, H. (1995) J. Biol. Chem. 270, 19141-19150 [Abstract/Free Full Text]
  24. Darnell, J. E., Jr., Kerr, I. M., and Stark, G. R. (1994) Science 264, 1415-1421 [Medline] [Order article via Infotrieve]
  25. Frank, S. J., Yi, W., Zhao, Y., Goldsmith, J. F., Gilliland, G., Jiang, J., Sakai, I., and Kraft, A. S. (1995) J. Biol. Chem. 270, 14776-14785 [Abstract/Free Full Text]
  26. Barber, D. L., and D'Andrea, A. D. (1994) Mol. Cell. Biol. 14, 6506-6514 [Abstract]
  27. Cooper, J. A., and Howell, B. (1993) Cell 73, 1051-1054 [Medline] [Order article via Infotrieve]
  28. Rao, P., and Mufson, R. A. (1995) J. Biol. Chem. 270, 6886-6893 [Abstract/Free Full Text]
  29. Webb, G. C., Jenkins, N. A., Largaespada, D. A., Copeland, N. G., Fernandez, C. S., and Bowtell, D. D. (1993) Genomics 18, 14-19 [CrossRef][Medline] [Order article via Infotrieve]
  30. Cen, H., Papageorge, A. G., Vass, W. C., Zhang, K. E., and Lowy, D. R. (1993) Mol. Cell. Biol. 13, 7718-7724 [Abstract]
  31. Tanaka, S., Morishita, T., Hashimoto, Y., Hattori, S., Nakamura, S., Shibuya, M., Matuoka, K., Takenawa, T., Kurata, T., Nagashima, K., and Matsuda, M. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 3443-3447 [Abstract]

©1995 by The American Society for Biochemistry and Molecular Biology, Inc.